Scientists' Contribution

Recent letters from Philip Siekevitz (The Scientist, June 22, 1992, page 12) and M.P. Thomas (The Scientist, July 20, 1992, page 12) misrepresented both the content and the intent of my commentary (The Scientist, May 11, 1992, page 12). In response to Thomas, I said nothing to demean the professional accomplishments of Radcliffe College president Linda Wilson, for which I have the highest regard, and I expressed qualified support for her views. In contrast to Thomas's unabashedly sexist letter,

Written byWm Grogan
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Recent letters from Philip Siekevitz (The Scientist, June 22, 1992, page 12) and M.P. Thomas (The Scientist, July 20, 1992, page 12) misrepresented both the content and the intent of my commentary (The Scientist, May 11, 1992, page 12). In response to Thomas, I said nothing to demean the professional accomplishments of Radcliffe College president Linda Wilson, for which I have the highest regard, and I expressed qualified support for her views. In contrast to Thomas's unabashedly sexist letter, I made no reference to Wilson's gender, nor did it enter into my consideration of her views. Thomas's pejorative use of "old boy" is no less reprehensible than any other race- or gender-based epithet intended to dismiss another class of people without confronting them as human beings.

In response to Siekevitz, it is not true that Grogan "refuses to recognize the social implications of scientific research...." What I addressed in my ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies